Choice of Vector

An overview of some of the most common vector systems is provided in Table 4.5. All the vectors chosen here are inducible expression systems. Induction can result from a change in temperature, from addition of metabolites, or from removal of a necessary carbon source. 

One of the crucial parts of any vector system is the promoter, a piece of DNA sequence which controls the level of protein expression. 

The hybrid tac promoter, a combination of lac and trp promoters, combines the high transcription efficiency of the trp promoter with the easy inducibility of the lac promoter. The lac promoter, like the other IPTG-inducible promoters, does not have tight repressor control, laclq E. coli strains with a large quantity of lacl repressor should always be used with this promoter possibly extra copies of lacl should even be provided (such as rep4 plasmid from Qiagen). 

T7 IPTG many vectors available, extremely high yields and low temperature possible tight control combined with pLysS or pLysE plasmids only, useful only with BL21 (DE3) strains 

Another tightly controlled promoter system (araB Invitrogen) is based on arab-inose. Induction of the promoter is totally repressed by sugars such as glucose or fructose, whereas transcription control can be leveled through control of the arab-inose concentration. 

---

The choice of vectors obviously depends upon the expression system that will be used and there is a wide availability of optimized reagents from both commercial and academic sources. For expression in E. coli, the most widely used system for HTP protein production is the pET/T7 promoter vector developed by Studier which makes use of T7 RNA polymerase to direct expression of cloned... 

The system used to deliver the desired gene into the cells, called the gene therapy vector, may be a virus, a plasmid, or even just the naked DNA. The choice of vector is based on the difficulty of getting the gene into the cell, the amount of DNA the vector can carry, the size of the gene sequence needed to provide the correct protein, and the effects the vector may have on the body. Each type of vector has advantages and disadvantages. 

Recall from Proposition 3.5 that given any finite-dimensional linear subspace W of a scalar product space V, there is an orthogonal projection fliv on V whose kernel is VP- -. Note that the expression giving the probability does not depend on the choice of vector in the equivalence class [v]. 

A range of different vaccine vectors has been developed over time to provoke an immune response within the body [127,142], However, it has only been comparatively recently that they have been applied to inducing mucosal immunity within the uterovaginal tract. The general vector platforms that have been used include attenuated viruses, live viruses, commensal bacteria, DNA vectors, and protein subunit/peptide or virus-like particles (Table 21.9). The choice of vector is dependent on a number of factors such as the pathogenic virus and bacterial type and the length of duration of immunity required. 

Therefore, a fixed order of the factors in PN is implied as indicated by Eq. (59). The symmetry of SSim(E) of Eq. (58) should be and is assumed to be enforced by an appropriate choice of vectors gv. In practice, this is difficult to express explicitly. However, determination of g by parameter fitting is impractical, anyway. The S matrix (58) is often very useful when gv need not be specified explicitly, as will be seen in the following, since it is quite a general representation that is unitary at real E and has poles at the right positions in the complex E plane. 

Since the OTC trial, there has been rapid advancement in vector development with marked improvements in the safety (and efficacy) of new viral delivery systems. There is also a better understanding of the immunological responses to gene therapy vectors. The adverse events in the SCID trial are more recent. They appear to be a likely result of the choice of vector (retrovirus) and the ex vivo selection strategy used to modify the affected stem cells of the SCID patients. The risk benefit ratio for gene therapy treatment of these children is still deemed favorable in light of the fact that without treatment, they would not be alive. 

Since most recombinant DNA occurs with bacterial and viral vectors, a big concern is that a mutated virus or bacteria will be released that can infect other species and that may be resistant to drugs, thereby creating a new, potentially lethal disease. Precautions include frequent sterilization of cultures to make sure that they are all dead before disposal, working in laminar hoods that isolate the recombinant DNA from the outside, and care in the choice of vectors. Some vectors that are replication-deficient outside certain cell types are used so that they cannot replicate outside the lab environment... 

As seen, the London orhitals are not invariant with respect to the choice of vector potential origin ... 

---